BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Iliac Artery

Below is an extended Iliac Artery patents listing. Click here to return to the Iliac Artery main in depth entry.

Patents :

US Patent No.Title
7309353 Use of platinum group metals in vascular devices and method of texturing platinum group metals
7331921 Implantable heart assist system and method of applying same
7331985 Apparatus and method for deployment of an endoluminal device
7335192 Apparatus and methods for treating congestive heart disease
7345148 Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides
7354449 Covered stent and method of covering a stent
7357796 Phototherapeutic wave guide apparatus
7358074 Human phosphatase RET31, and variants thereof
7364566 Method and apparatus for intra-aortic substance delivery to a branch vessel
7371388 Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7374531 Long term ambulatory intra-aortic balloon pump with three dimensional tortuous shape
7329661 N-phenyl-3-pyrimidine-amine derivatives
7326244 Intravascular folded tubular endoprosthesis
7326237 Supra-renal anchoring prosthesis
7312051 Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule
7312216 N-phenyl-2-pyrimidine-amine derivatives
7314483 Stent graft with branch leg
7314484 Methods and devices for treating aneurysms
7316711 Intralumenal stent device for use in body lumens of various diameters
7320703 Method for inserting a prosthesis
7320704 Nonstented temporary valve for cardiovascular therapy
7323006 Rapid exchange interventional devices and methods
7323008 Flexible stent
7324675 Quantification of aortoiliac endoluminal irregularity
7379574 Quantification of vascular irregularity
7381218 System and method for implanting a two-part prosthetic heart valve
7407509 Branched vessel endoluminal device with fenestration
7411054 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7414044 Use of targeted oxidative therapeutic formulation in treatment of type 2 diabetes
7415883 Method for protecting resonating sensors and open protected resonating sensors
7416555 Intravascular material removal device
7417048 Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets
7423175 Hydroxy-tetrahydro-naphthalenylurea derivatives
7425219 System and method for endoluminal grafting of bifurcated and branched vessels
7425326 Use of collagenase to facilitate guide wire crossing in total arterial occlusions
7427199 Models and methods of using same for testing medical devices
7404821 Treatment for post partum hemorrhage
7402312 Antibodies to vascular endothelial growth factor 2 (VEGF-2)
7402141 Catheter guidewire system using concentric wires
7381800 Antibodies to HBIMF63 polypeptide
7381840 Tetrahydro-naphthalene derivatives
7384411 Multi-purpose catheters, catheter systems, and radiation treatment
7388074 Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof
7390637 Keratinocyte derived interferon
7390821 Methods of reducing angiogenesis
7393357 Endovascular stent graft
7393934 Human G-protein chemokine receptor (CCR5) HDGNR10
7396821 Intravascular delivery of nucleic acid
7399313 Endovascular graft with separable sensors
7427602 Sustained DNA delivery from structural matrices
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional